Nabi Biopharmaceuticals
Nabi Biopharmaceuticals (Nasdaq:NABI) leverage its experience and knowledge in powering the human immune system to develop and market products that target serious medical conditions in the areas of transplantation, infectious disease and hematology/oncology.
RSS Headlines
Fool UK